Vita Life Sciences Limited (ASX:VLS) announces a share repurchase program. Under the program, the company will repurchase up to 8,325,392 shares, representing 15% of its issued share capital. The purpose of the buyback is capital management.

The plan will be valid up to the Annual General Meeting in 2023 and May 10, 2023. As of May 11, 2022, the company has 55,502,612 shares in issue.